Last edition
News about "the United States Food and Drug Administration (US"
Zydus Lifesciences Receives USFDA Tentative Nod for Generic Multiple Sclerosis Drug
Zydus Lifesciences has received tentative approval from the United States Food and Drug Administration (USFDA) for Diroximel Fumarate delayed-release capsules, 231 mg, a generic version of Vumerity delayed-release capsules of the same strength.
The United States Food And Drug Administration (US | 13/11/2025 | By Dineshwori | 108
Cipla's Bommasandra Facility Gets VAI Classification from USFDA
Cipla has announced that its manufacturing facility in Bommasandra, Bengaluru, has received a Voluntary Action Indicated (VAI) classification from the USFDA following a recent inspection.
The United States Food And Drug Administration (US | 06/08/2025 | By Dineshwori | 202
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy